BioCentury
ARTICLE | Financial News

Favrille raises $16.9 million

June 11, 2002 7:00 AM UTC

Pharmacogenomics company Favrille (San Diego, Calif.) raised $16.9 million in a series B round led by Sanderling Ventures. Other investors included De Novo Ventures; Indofin; Lotus BioScience Investme...